FDA Authorizes Use of Plasma From Recovered Patients to Treat COVID-19
(WASHINGTON) — President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,” one of his top health officials called “promising” and other health experts said needs more study before it’s celebrated.
The announcement came after White House officials complained there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances.
On the eve of the Republican National Convention, Trump put himself at the center of the FDA’s announcement of the authorization at a news conference Sunday evening. The authorization makes it easier for some patients to obtain the treatment but is not the same as full FDA approval.
The blood plasma, taken from patients who have recovered from the coronavirus and rich in antibodies, may provide benefits to those battling the disease. But the evidence so far has not been conclusive about whether it works, when to administer it and what dose is needed.
In a letter describing the emergency authorization, the chief scientist for the FDA, Denise Hinton, said: “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months....
Source: TIME: Health - Category: Consumer Health News Authors: Jonathan Lemire an Mike Stobbe / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news
More News: American Health | Biochemistry | Biology | Clinical Trials | Conferences | Coronavirus | COVID-19 | Emergency Medicine | Food and Drug Administration (FDA) | Government | Health | Hospitals | Hydroxychloroquine | Infectious Diseases | International Medicine & Public Health | John Hopkins University | Malaria | Malaria Vaccine | Measles | Measles Vaccine | Molecular Biology | Obama | Politics | Science | Study | Toxicology | Trump | USA Health | Vaccines